IHEA Econ-Omics SIG

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @eigen-uom.bsky.social @zanfinaa.bsky.social @hadleyssmith.bsky.social @sallysansom.bsky.social

(9/9) 👏 Congratulations to all authors, and thank you to the Econ-Omics community for helping spotlight these impactful publications.

#IHEA #EconOmics #HealthEconomics #Genomics #PrecisionMedicine #ArrowAward

(8/9)
• Schilling, C., et al. Use of subsidised genetic & genomic testing (2014–2023). Eur J Hum Genet, 2025.
• Smith, H.S., et al. Distributional CEA in genomic medicine. Value in Health, 2025.

(7/9)
• Goranitis, I., et al. The GUV Scale. Value in Health, 2025.
• Peters, R., et al. Public preferences for genomic newborn screening. Am J Hum Genet, 2025.
• Santos Gonzalez, F., et al. Microcosting genomics: Challenges & opportunities. Genetics in Medicine, 2025.

(6/9)
• Buchanan, J., Goranitis, I., & Weymann, D. The health economics of genomic technologies. Appl Health Econ Health Policy, 2025.
• Goranitis, I., et al. Determining the value of genomics in healthcare. Nature Medicine, 2025.

(5/9)
• Best, S., et al. Using implementation science to integrate genomics into healthcare. Nature Medicine, 2025.
• Bourke, M., et al. Cost-effectiveness of genomic medicine in cancer control. Appl Health Econ Health Policy, 2025.

(4/9)
• Abbott, M., et al. Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis. Appl Health Econ Health Policy, 2025.
• Akbarzadeh Khorshidi, H., et al. Implementation of WGS in cancer management. Discover Oncology, 2025.

(3/9) 🌟 Top community pick

Goranitis, I., et al. (2025). Determining the value of genomics in healthcare. Nature Medicine.

Now, the full list—unranked & alphabetical 👇

(2/9) We’re excited to share the Top 10 papers identified by our community as particularly important for advancing health economics in genomics & precision medicine.

These results informed the SIG’s submission to the IHEA Arrow Award.

(1/9) 📣 The Econ-Omics Survey Results Are In!

Thanks to everyone who participated in the IHEA Economics of Genomics & Precision Medicine (Econ-Omics) SIG survey nominating influential papers published in 2025. 👇

Deadline extended to Friday 16 January!

Please complete this survey to nominate important or impactful 2025 papers for #healtheconomics in #genomics & #precisionmedicine: q.surveys.unimelb.edu.au/jfe/form/SV_...

Top papers will be submitted for the #IHEA #ArrowAward!

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @eigen-uom.bsky.social @zanfinaa.bsky.social @hadleyssmith.bsky.social @sallysansom.bsky.social

📣 Please complete a short survey nominating important or impactful 2025 papers for #healtheconomics in #genomics & #precisionmedicine. Top papers will be submitted for the #IHEA #ArrowAward.

🗓️ Deadline: 12 Jan 2026
🔗 q.surveys.unimelb.edu.au/jfe/form/SV_...

HERC Webinar: Hadley Stevens Smith - From Crib to Clinic: The Economic and Ethical Trade-offs of Genomic Sequencing in Newborn Screening and Diagnosis Online surveys is a powerful, easy to use tool for creating online surveys. Run by Jisc, online surveys is used by over 300 different organisations in the UK...

UPCOMING WEBINAR

From Crib to Clinic: The Economic and Ethical Trade-offs of Genomic Sequencing in Newborn Screening and Diagnosis

Dr @hadleyssmith.bsky.social

Tues 21 Oct 10:30 h UK BST onsite/online

Free event registration app.onlinesurveys.jisc.ac.uk/s/oxford/her...

@oxpop.bsky.social

The recording from this webinar is now available! www.youtube.com/watch?v=8t7x...

#healthpolicy #healthequity #DCEA #HTA #healtheconomics #genomics #precisionmedicine #IHEA

(4/4) We hope to see you there! #healthpolicy #healthequity #DCEA #HTA #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @zanfinaa.bsky.social @sallysansom.bsky.social

(3/4) @hadleyssmith.bsky.social (@harvardmed.bsky.social‬) will share a framework for equity in genomics, highlighting data equity, evidence standards & how #DCEA can guide fairer decisions in precision health

(2/4) Melanie Lloyd (@monashuniversity.bsky.social‬) will explore how #DCEA differs from traditional CEA, showing through a gestational diabetes case study how implementation choices shape the balance between equity & efficiency in healthcare

(1/4) TWO-WEEKS: Webinar exploring distributional cost-effectiveness analysis (#DCEA) in #genomicmedicine

🗓️ Date & time: 6-7pm Wed 8 Oct EDT / 10-11pm Wed 8 Oct UTC / 9-10am Thurs 9 Oct AEDT
📍 Online, download the calendar invitation (+Zoom link) here: healtheconomics.org/event/advanc...

The recording from this event is now available! #mendelianrandomisation #mendelianrandomization #genomics #healtheconomics #costeffectiveness #CEA

www.youtube.com/watch?v=ui0n...

(1/3) 🎙️ New episode from the Centre for Personalised Medicine podcast!

We explore the “#HealthEconomics of #PersonalisedMedicine” with host @rachel-horton.bsky.social and expert guests

🎧 Listen:
Apple: podcasts.apple.com/gb/podcast/s...
Spotify: open.spotify.com/episode/1Q9Y...

(4/4) We hope to see you there! #mendelianrandomisation #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @sallysansom.bsky.social

(3/4) @padraigdixon.bsky.social (University of Oxford) will present a novel approach to estimate long-term cost-effectiveness of health interventions without RCTs/Markov models.‬ Using a prostate cancer prevention case study, he’ll show how MR can link genetic liability to healthcare costs & QALYs.

(2/4) @zanfinaa.bsky.social (Monash University) will discuss how health economic models help set healthcare priorities & evaluate intervention value - especially given the limits of RCTs. Using CVD prevention as a case study, she’ll show how Mendelian randomization can improve RWE in CEA.

(1/4) TOMORROW: Applying #MendelianRandomization in #HealthEconomics - Bridging #Genomics & #CostEffectiveness
🗓️ Tues 16 Sept

⏰ 8-9 AM UTC / 9-10 AM BST / 6-7 PM AEST
📍 Online, download the calendar invite (incl. the Zoom link) here: healtheconomics.org/event/applyi...

(4/4) We hope to see you there! #healthpolicy #healthequity #DCEA #HTA #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @zanfinaa.bsky.social sky.social @sallysansom.bsky.social

(3/4) Dr @hadleyssmith.bsky.social (@harvardmed.bsky.social) will share a framework for equity in genomics, highlighting data equity, evidence standards & how #DCEA can guide fairer decisions in precision health

(2/4) Dr Melanie Lloyd (@monashuniversity.bsky.social) will explore how DCEA differs from traditional CEA, showing through a gestational diabetes case study how implementation choices shape the balance between equity & efficiency in healthcare

(1/4) NEXT MONTH: Webinar exploring distributional cost-effectiveness analysis for advancing #healthequity in #genomicmedicine

🗓️ Date & time: 6-7pm Wed 8 Oct EDT / 10-11pm Wed 8 Oct UTC / 9-10am Thurs 9 Oct AEDT
📍 Online, download the calendar invitation here: healtheconomics.org/event/advanc...

(4/4) We hope to see you there! #mendelianrandomisation #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @sallysansom.bsky.social